Scottish Equitable is maintaining cover for angioplasty under its critical-illness offering despite a big number of insurers dropping cover for the treatment.
Several of ScotEq's rivals, including Friends Provident, Legal & General, Norwich Union, Scottish Provident and Standard Life, have pulled the plug on cover for the treatment, arguing that it is a relatively simple procedure that requires a short recovery time, with some patients back at work within 10 days.
As a result of its removal, providers say they have been able to continue offering guaranteed rates but ScotEq, which does not have guaranteed rates, says it will continue angioplasty as a core condition on reviewable rates.
ScotEq is offering a pamphlet to IFAs next week entitled, Helping You Understand Angioplasty.
Head of underwriting Matt Rann says: “Let us be realistic – angioplasty is a critical event and we have no plans to remove it from our critical list.”
But Lifesearch spokesman Kevin Carr says: “The fact that ScotEq is leaving angioplasty on their critical list has little effect on us. Approximately half of the industry has taken it off. Angioplasty used to be a major procedure and it no longer is.”